Tempest Therapeutics Inc (TPST) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Tempest Therapeutics Inc   (NASDAQ: TPST)


Tempest Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Tempest Therapeutics Inc's ROI in the second quarter of 2026?
Tempest Therapeutics Inc recorded a cumulative net loss of $-40 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -372.85%.

Within the Healthcare sector 744 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 4127 to 4252.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -37.14 % -18.53 % -8.41 % -17.95 % -17.7 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 5 9 15 15 18
Return On Investment (TTM) -372.85 % -304.14 % -154.36 % -199.27 % -249.57 %
TPST's Overall Ranking # 4252 # 4127 # 3651 # 1263 # 3829
Seq. Investment Change TTM -23.4 % -16.71 % -5.97 % 4.77 % -0.72 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -40 -43 -26 -36 -43

TPST Company Profile >> Back to TPST Roi Comparisons >> See Annual TPST Return On Investment



Return On Investment TPST's Ranking
Within: No.
Industry # 354
Sector # 745
Overall # 4252

Return On Investment Statistics
High Average Low
-33.51 %
-142.1 %
-1642.37 %
(Sep 30 2022)   (Mar 31 2020)



  News about Tempest Therapeutics Inc Return on Investment ROI

Tempest Therapeutics Inc Appoints Troy M. Wagner as Vice President of Quality Assurance, Reinforcing Global Clinical Leadership Team and Addressing Financial Challenges,

August 21, 2024


Expansion of leadership team to strengthen global clinical expertise
Tempest Therapeutics Inc, a leading healthcare company, has recently appointed Troy M. Wagner as its new Vice President of Quality Assurance. This strategic move aims to expand the company s leadership team and further enhance its global clinical expertise.
During the 12 months ending in the third quarter of 2023, Tempest Therapeutics Inc experienced a cumulative net loss of $31 million. This resulted in a negative return on investment (ROI) of -182.82%. This challenging financial situation has led the company to recognize the need for strengthening its leadership team.





Financial Statements
Tempest Therapeutics Inc's II. Quarter Investments $ 5 Millions TPST's Balance sheet
Tempest Therapeutics Inc's II. Quarter Income $ -5 Millions Quarterly TPST's Income Statement
TPST's Income by Division See TPST's Income by Division


TPST Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 7 19 33 28 51
Y / Y Investment Growth -65.14 % -42.1 % 15.98 % -44.36 % 48.56 %
Net Income in Millions -26 -42 -29 -36 -28
Y / Y Net Income Growth - - - - -
Annual Return On Investment -393.85 % -218.78 % -89.28 % -125.37 % -55.29 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TPST's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TPST's Competitors
Subscribers only: Roi for Tempest Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for TPST's Customers

Other Ratios
TPST's Roa TPST's Inventory Turnover Ratio TPST's Growth Rates TPST's Dividend Statistics
TPST's Profitability Ratios TPST's Asset Turnover Ratio TPST's Dividend Growth
TPST's Roe TPST's Valuation Ratios TPST's Financial Strength Ratios TPST's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-03T12:19:59+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.